4.8 Article

Fusobacterium nucleatum Aggravates the Progression of Colitis by Regulating M1 Macrophage Polarization via AKT2 Pathway

Journal

FRONTIERS IN IMMUNOLOGY
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2019.01324

Keywords

Fusobacterium nucleatum; ulcerative colitis; gut microbiota; M1 macrophage; mucosal barrier

Categories

Funding

  1. National Natural Science Foundation of China [81570480, 81770529]
  2. Special Scientific Research Fund of Public Welfare Profession of National Health and Family Planning Commission [201502026]
  3. Key Scientific and Technological Program of Guangzhou City [201607020016]

Ask authors/readers for more resources

Disordered intestinal flora and discordant immune response are associated with the development of ulcerative colitis (UC). Recent work has described the ability of macrophages to undergo repolarization toward a proinflammatory M1 or anti-inflammatory M2 phenotype in response to particular bacterium-derived signals. Fusobacteriumnucleatum(F. nucleatum, Fn) is a species of intestinal commensal bacteria with potential pathogenicity, but its association with UC and how it may contribute to progression of UC is largely unknown. In this study, we provide new evidence that F. nucleatum accumulated heavily in the intestine of UC patients and was accompanied by the secretion of IFN-gamma and the skewing of M1 macrophages. Mechanistically, our data showed that F. nucleatum aggravated dextran sodium sulfate (DSS)-induced colitis in the production of Th1-related cytokines IFN-gamma through the AKT2 signaling pathway in vitro and in vivo. To further confirm the disease-relevance of these shifts in macrophage repolarization in response to F. nucleatum, stimulated bone marrow-derived macrophages (BMDMs) were transferred into recipientmice with DSS colitis. This transfer resulted in increased disease activity and inflammatory cytokine production. Taken together, we show clearly that F. nucleatum can promote the progression of UC via proinflammatory M1 macrophage skewing, and targeting F. nucleatum or AKT2 signaling may be a viable means of blocking development of UC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Metformin protects against intestinal barrier dysfunction via AMPKα1-dependent inhibition of JNK signalling activation

Jun Deng, Lishan Zeng, Xueying Lai, Jing Li, Le Liu, Qianyun Lin, Ye Chen

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)

Article Microbiology

Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction

Youlian Zhou, Zhenjiang Zech Xu, Yan He, Yunsheng Yang, Le Liu, Qianyun Lin, Yugiang Nie, Mingsong Li, Fachao Zhi, Side Liu, Amnon Amir, Antonio Gonzalez, Anupriya Tripathi, Minhu Chen, Gary D. Wu, Rob Knight, Hongwei Zhou, Ye Chen

MSYSTEMS (2018)

Article Medicine, Research & Experimental

An engineering probiotic producing defensin-5 ameliorating dextran sodium sulfate-induced mice colitis via Inhibiting NF-kB pathway

Lishan Zeng, Jiasheng Tan, Meng Xue, Le Liu, Mingming Wang, Liping Liang, Jun Deng, Wei Chen, Ye Chen

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Article Cell Biology

PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation

Ming-Yue Wu, Le Liu, Er-Jin Wang, Hai-Tao Xiao, Cui-Zan Cai, Jing Wang, Huanxing Su, Yitao Wang, Jieqiong Tan, Zhuohua Zhang, Juan Wang, Maojing Yao, De-Fang Ouyang, Zhenyu Yue, Min Li, Ye Chen, Zhao-Xiang Bian, Jia-Hong Lu

Summary: NRBF2, a regulatory subunit of the ATG14-BECN1/Beclin 1-PIK3C3/VPS34 complex, plays a crucial role in clearing apoptotic cells and alleviating colitis by promoting the fusion of phagosomes and lysosomes through the generation of active RAB7. Increased NRBF2 expression in colon macrophages is associated with a protective role in ulcerative colitis, highlighting the importance of apoptotic cell clearance in maintaining intestinal homeostasis and reducing inflammation.

AUTOPHAGY (2021)

Article Gastroenterology & Hepatology

The appropriate cutoff gastric pH value forHelicobacter pylorieradication with bismuth-based quadruple therapy

Haoran Ke, Jing Li, Bingyun Lu, Chenghai Yang, Jiamin Wang, Zhiqing Wang, Le Liu, Ye Chen

Summary: Double dose esomeprazole is associated with better intragastric acid suppression. A median 24-h intragastric pH of 5.7 could be an appropriate cutoff value for predicting the successful eradication of H. pylori. Bismuth-based quadruple therapy resulted in high H. pylori eradication rates in both PPI standard or double doses.

HELICOBACTER (2021)

Article Cell Biology

Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase

Shijie Mai, Le Liu, Jianjun Jiang, Pengfei Ren, Dingwei Diao, Haofei Wang, Kaican Cai

Summary: The study revealed an oncogenic role of IL-33 in promoting ESCC tumor growth by inducing M2-like macrophage differentiation through ODC activation. This suggests IL-33 as a potential novel target for cancer immunotherapy.

CELL PROLIFERATION (2021)

Article Nutrition & Dietetics

Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases

Youlian Zhou, Yan He, Le Liu, Wanyan Zhou, Pu Wang, Han Hu, Yuqiang Nie, Ye Chen

Summary: The study revealed differences in gut microbiota between Chinese and Western populations, as well as distinct microbial characteristics in UC and cCD patients in China. Gardnerella and Fusobacterium were identified as potential biomarkers for distinguishing between UC and cCD, demonstrating an important association between IBD affected bowel region and gut microbiota.

FRONTIERS IN NUTRITION (2021)

Article Gastroenterology & Hepatology

Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial

Chenghai Yang, Liping Liang, Pinjing Lv, Le Liu, Siqi Wang, Zhiqing Wang, Ye Chen

Summary: The study found that supplementation of non-viable L. reuteri DSM17648 with triple therapy did not increase the eradication rate of H. pylori, but helped improve the gut microbiota and reduce the frequencies of abdominal distention, diarrhea, and overall gastrointestinal symptom rating.

HELICOBACTER (2021)

Article Biochemistry & Molecular Biology

A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients

Le Liu, Liping Liang, Genghui Mai, Ye Chen

Summary: This study identifies a 12-FAMRG risk signature for predicting prognosis and response to immunotherapy in colon adenocarcinoma (COAD). The risk signature is significantly correlated with prognosis and medication resistance in COAD patients. Additionally, the study reveals a strong correlation between the risk signature and immune cell infiltration and immune modulation.

FASEB BIOADVANCES (2022)

Article Gastroenterology & Hepatology

Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway

Le Liu, Liping Liang, Chenghai Yang, Youlian Zhou, Ye Chen

Summary: The study demonstrated that Fusobacterium nucleatum-derived extracellular vesicles induce epithelial cell death and gut barrier disruption in ulcerative colitis, potentially through the activation of receptor-interacting protein kinase 1 (RIPK1). These findings provide insights for further investigation of the disease.

GUT MICROBES (2021)

No Data Available